Aileron Therapeutics, Inc.
USD2.11
+0.18 (+9.33%)
CEO
James Brian Windsor
IPO Date
2017-06-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.97
Prev. Close
$1.93
Day Low
$1.96
Day High
$2.17
52W Low
$1.61
52W High
$7.42
Market Cap
$0.05B
Volume
0.06M
| -0.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -0.2% | -0.0% | 0.01 | 4.17 | -619.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -0.1% | -0.1% | 0.00 | 6.46 | -352.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -0.1% | -0.1% | 0.00 | 10.69 | -359.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -0.2% | -0.1% | 0.03 | 4.12 | -1746.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.31 | 3.35 | 0.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.27 | 4.05 | 0.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 10.60 | 0.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 5.18 | 0.0 |
| -0.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -12.1% | -10.4% | 0.00 | 0.90 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -226.8% | -11.9% | 0.00 | 0.86 | -1.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -112.9% | -9.5% | 0.00 | 1.39 | -1.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -75.3% | -59.2% | 0.00 | 2.38 | -0.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -11.6% | -5.6% | 0.00 | 3.30 | -2.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -0.0% | -0.0% | 0.00 | 4.69 | -1180.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -0.0% | -0.0% | 0.00 | 2.82 | -618.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -0.1% | -0.0% | 0.01 | 4.17 | -344.4 |